The hemostasis test panel includes the measurement of prothrombin time (PT), partial thromboplastin (activated) (aPTT), and fibrinogen (Fib) level according to the Clauss method, as well as thrombin time. The precision of these examinations, carried out routinely by analysis laboratories, is essential.

Stago, leader in the exploration of hemostasis and thrombosis, has developed the sthemO 301 analyzer for medical biology laboratories. This device is equipped with new reagents and applications for hemostasis tests: sthemO PT M, sthemO PTT A, sthemO CK Prest, sthemO Fib M and sthemO Thrombin M.

Amarok Biotechnologies conducted an accuracy assessment of these applications, at both single-site and multi-site levels, in accordance with CLSI EP05-A3.

The data obtained shows precision and reproducibility over the entire measurement range for each test. The coefficients of variation (CV%) are in full compliance with the GFHT recommendations. These results validate the potential of the Stago sthemO 301 analyzer as an essential and reliable instrument for clinical laboratories. In addition, optimized reagent preparation, without the need for additional accessories, marks another step forward for laboratory efficiency!